That's not the reason overpriced their ipo. It's a textbook example. Their growth has been ok. Lots of reasons really. Their lack of growth for revenue for the latest quarter has killed enthusiasm for a while anyways.
- Forums
- ASX - By Stock
- LBY
- Ann: Laybuy Investor Webinar on Thursday 28 October
Ann: Laybuy Investor Webinar on Thursday 28 October, page-11
Featured News
Add LBY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online